Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.

Paxillin anticorps (C-Term)

PXN Reactivité: Humain WB, IHC, IC Hôte: Lapin Polyclonal unconjugated

N° du produit ABIN2331015

Fiche de données

Antigène Voir toutes Paxillin (PXN) Anticorps

Paxillin (PXN)
Épitope
31

26

17

16

11

9

7

7

6

6

6

5

4

3

3

3

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
C-Term
Reactivité
194

108

77

22

11

9

8

5

3

3

1

1

1

1

1
Humain
Hôte
182

29

1
Lapin
Anticorps secondaires appropriés
Clonalité
172

40
Polyclonal
Conjugué
115

10

8

8

8

8

8

8

6

6

4

4

4

4

4

2

2

2

1
Cet anticorp Paxillin est non-conjugé
Application
160

59

41

40

40

27

25

22

20

14

13

5

2

2

2

1

1

1
Western Blotting (WB), Immunohistochemistry (IHC), Immunochromatography (IC)

Réactivité croisée

Humain, Souris, Rat (Rattus)

Réactivité croisée (Details)

Calculated cross reactivity: Hu Mo Rt

Attributs du produit

Paxillin (PXN)

Purification

Purified by immunoaffinity chromatography.

Immunogène

A synthetic peptide corresponding to a sequence at the C-terminal of human PXN, identical to the related mouse and rat sequences.

Isotype

IgG

Top Product

Discover our top product PXN Anticorps primaire
anti-Paxillin (PXN) (AA 201-461) antibody
PXN Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated

anti-Paxillin (PXN) (AA 347-578) antibody
PXN Reactivité: Souris WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated

anti-Paxillin (PXN) (AA 1-262) antibody
PXN Reactivité: Humain WB, PLA Hôte: Lapin Polyclonal unconjugated

anti-Paxillin (PXN) (AA 327-568) antibody
PXN Reactivité: Rat WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated

anti-Paxillin (PXN) (AA 456-472) antibody
PXN Reactivité: Humain, Souris, Rat WB, IHC (p), ICC, IHC (fro) Hôte: Lapin Polyclonal unconjugated

anti-Paxillin (PXN) (AA 1-557) antibody
PXN Reactivité: Humain, Souris, Rat, Poulet, Chien WB, IHC, IF, IP Hôte: Souris Monoclonal 165-Paxillin unconjugated

anti-Paxillin (PXN) (AA 456-472), (C-Term) antibody
PXN Reactivité: Humain, Souris, Rat WB, IHC (p), ICC, IHC (fro) Hôte: Lapin Polyclonal unconjugated

anti-Paxillin (PXN) (pTyr118) antibody
PXN Reactivité: Humain, Souris, Rat WB, ELISA Hôte: Lapin Polyclonal unconjugated

anti-Paxillin (PXN) (AA 94-125) antibody
PXN Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB15414 unconjugated

anti-Paxillin (PXN) (AA 1-262) antibody
PXN Reactivité: Humain WB, IP Hôte: Lapin Polyclonal unconjugated

Indications d'application

Optimal working conditions should be determined by the investigator.

Restrictions

For Research Use only
Format

Lyophilized

Reconstitution

Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

Buffer

Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.

Agent conservateur

Sodium azide, Thimerosal (Merthiolate)

Précaution d'utilisation

This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.

Stock

4 °C,-20 °C

Stockage commentaire

4°C/-20°C
Antigène

Paxillin (PXN)

Autre désignation

Paxillin (PXN Produits)

Synonymes

anticorps AW108311, anticorps AW123232, anticorps Pax, anticorps CG18061, anticorps CG18576, anticorps CG31794, anticorps CT40481, anticorps CT42454, anticorps DPaxillin, anticorps DPxn, anticorps DPxn37, anticorps Dmel\\CG31794, anticorps Dpax, anticorps DpaxA, anticorps PDLP, anticorps dPax, anticorps pax, anticorps wu:fw71f12, anticorps PXN, anticorps LOC100220858, anticorps paxillin, anticorps Paxillin, anticorps paxillin S homeolog, anticorps paxillin a, anticorps PXN, anticorps Pxn, anticorps Pax, anticorps pxn.S, anticorps pxna, anticorps LOC696336, anticorps pxn

UniProt

P49023

Pathways

Signalisation MAPK, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling